Concepts (181)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insecticides | 13 | 2022 | 44 | 5.800 |
Why?
|
| Permethrin | 7 | 2019 | 10 | 3.870 |
Why?
|
| Adipogenesis | 9 | 2019 | 79 | 3.660 |
Why?
|
| Linoleic Acids, Conjugated | 10 | 2018 | 13 | 3.340 |
Why?
|
| Adipocytes | 9 | 2019 | 269 | 3.210 |
Why?
|
| Caenorhabditis elegans | 10 | 2021 | 677 | 3.080 |
Why?
|
| Triglycerides | 10 | 2019 | 244 | 2.540 |
Why?
|
| Obesity | 7 | 2022 | 1232 | 1.650 |
Why?
|
| Caenorhabditis elegans Proteins | 4 | 2021 | 427 | 1.510 |
Why?
|
| Fats | 3 | 2019 | 20 | 1.320 |
Why?
|
| Ivermectin | 2 | 2019 | 24 | 1.240 |
Why?
|
| Lipid Metabolism | 3 | 2019 | 221 | 1.220 |
Why?
|
| Insulin Resistance | 3 | 2017 | 411 | 1.220 |
Why?
|
| AMP-Activated Protein Kinases | 3 | 2017 | 85 | 1.150 |
Why?
|
| Energy Metabolism | 4 | 2019 | 379 | 1.110 |
Why?
|
| Hepatocytes | 2 | 2019 | 217 | 1.070 |
Why?
|
| Animals | 30 | 2022 | 20649 | 1.060 |
Why?
|
| 3T3-L1 Cells | 8 | 2019 | 90 | 0.950 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2017 | 93 | 0.950 |
Why?
|
| Plant Extracts | 2 | 2019 | 172 | 0.940 |
Why?
|
| Endoplasmic Reticulum Stress | 3 | 2019 | 44 | 0.860 |
Why?
|
| Signal Transduction | 5 | 2021 | 3027 | 0.850 |
Why?
|
| Lipids | 2 | 2016 | 316 | 0.820 |
Why?
|
| Nitriles | 3 | 2019 | 70 | 0.820 |
Why?
|
| Models, Animal | 3 | 2019 | 236 | 0.810 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2022 | 689 | 0.780 |
Why?
|
| Muscle, Skeletal | 3 | 2016 | 739 | 0.780 |
Why?
|
| PPAR gamma | 3 | 2019 | 76 | 0.780 |
Why?
|
| Adipose Tissue | 4 | 2019 | 296 | 0.770 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2019 | 147 | 0.740 |
Why?
|
| Pyruvaldehyde | 1 | 2021 | 6 | 0.720 |
Why?
|
| Mice | 17 | 2019 | 10839 | 0.720 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2018 | 72 | 0.720 |
Why?
|
| Cell Differentiation | 5 | 2019 | 1351 | 0.710 |
Why?
|
| Pyrethrins | 2 | 2019 | 9 | 0.700 |
Why?
|
| Alkanesulfonic Acids | 1 | 2020 | 6 | 0.690 |
Why?
|
| Environmental Pollutants | 1 | 2022 | 94 | 0.690 |
Why?
|
| Sulfonic Acids | 1 | 2020 | 8 | 0.690 |
Why?
|
| Emulsions | 3 | 2019 | 472 | 0.670 |
Why?
|
| Gene Expression Regulation | 3 | 2016 | 1615 | 0.660 |
Why?
|
| Fluorocarbons | 1 | 2020 | 38 | 0.660 |
Why?
|
| Diterpenes | 1 | 2019 | 21 | 0.640 |
Why?
|
| Glucose | 3 | 2017 | 470 | 0.640 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2019 | 10 | 0.640 |
Why?
|
| Fatty Acid Desaturases | 1 | 2019 | 9 | 0.640 |
Why?
|
| Environmental Exposure | 2 | 2022 | 219 | 0.640 |
Why?
|
| Antiparasitic Agents | 1 | 2019 | 9 | 0.630 |
Why?
|
| Dietary Supplements | 3 | 2019 | 233 | 0.630 |
Why?
|
| Cell Membrane | 1 | 2022 | 493 | 0.620 |
Why?
|
| Lipogenesis | 1 | 2019 | 68 | 0.580 |
Why?
|
| Dietary Fats | 2 | 2017 | 176 | 0.570 |
Why?
|
| Curcumin | 1 | 2019 | 80 | 0.560 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2017 | 43 | 0.560 |
Why?
|
| Food | 1 | 2017 | 76 | 0.540 |
Why?
|
| Particle Size | 1 | 2019 | 407 | 0.540 |
Why?
|
| Body Weight | 5 | 2017 | 377 | 0.540 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2018 | 217 | 0.540 |
Why?
|
| Drug Carriers | 1 | 2019 | 179 | 0.530 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 226 | 0.530 |
Why?
|
| Performance-Enhancing Substances | 1 | 2016 | 1 | 0.530 |
Why?
|
| Diet, High-Fat | 1 | 2017 | 174 | 0.520 |
Why?
|
| Body Composition | 4 | 2016 | 152 | 0.510 |
Why?
|
| Physical Endurance | 1 | 2016 | 48 | 0.510 |
Why?
|
| Drug Delivery Systems | 2 | 2019 | 326 | 0.510 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 203 | 0.510 |
Why?
|
| DDT | 1 | 2016 | 3 | 0.510 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 1 | 2016 | 5 | 0.500 |
Why?
|
| Potassium Chloride | 1 | 2015 | 15 | 0.500 |
Why?
|
| Functional Food | 1 | 2016 | 37 | 0.490 |
Why?
|
| Polysorbates | 1 | 2015 | 41 | 0.490 |
Why?
|
| Pyrazoles | 1 | 2016 | 78 | 0.480 |
Why?
|
| Sodium Chloride | 1 | 2015 | 63 | 0.480 |
Why?
|
| Aging | 2 | 2017 | 745 | 0.460 |
Why?
|
| Dietary Fats, Unsaturated | 2 | 2012 | 20 | 0.450 |
Why?
|
| Motor Activity | 1 | 2017 | 346 | 0.450 |
Why?
|
| Vaccinium macrocarpon | 1 | 2014 | 6 | 0.450 |
Why?
|
| Dextran Sulfate | 1 | 2014 | 40 | 0.440 |
Why?
|
| Calcium | 1 | 2017 | 573 | 0.430 |
Why?
|
| Nanoparticles | 2 | 2019 | 518 | 0.420 |
Why?
|
| Insulin | 1 | 2017 | 687 | 0.420 |
Why?
|
| Colitis | 1 | 2014 | 77 | 0.420 |
Why?
|
| Transcription Factors | 1 | 2021 | 1512 | 0.410 |
Why?
|
| Nitro Compounds | 1 | 2012 | 15 | 0.410 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2014 | 101 | 0.400 |
Why?
|
| Imidazoles | 1 | 2012 | 81 | 0.390 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2012 | 28 | 0.380 |
Why?
|
| Health Promotion | 1 | 2016 | 493 | 0.360 |
Why?
|
| Movement | 1 | 2012 | 155 | 0.350 |
Why?
|
| Phosphorylation | 3 | 2018 | 937 | 0.350 |
Why?
|
| Alzheimer Disease | 1 | 2017 | 720 | 0.340 |
Why?
|
| Random Allocation | 4 | 2016 | 198 | 0.340 |
Why?
|
| Homeostasis | 3 | 2017 | 369 | 0.330 |
Why?
|
| Membrane Potentials | 2 | 2022 | 141 | 0.330 |
Why?
|
| Hep G2 Cells | 2 | 2019 | 28 | 0.300 |
Why?
|
| Calcium, Dietary | 1 | 2008 | 29 | 0.300 |
Why?
|
| Locomotion | 2 | 2021 | 116 | 0.290 |
Why?
|
| Diet | 4 | 2016 | 525 | 0.290 |
Why?
|
| Bone Density | 1 | 2008 | 134 | 0.280 |
Why?
|
| Anti-Obesity Agents | 1 | 2007 | 14 | 0.280 |
Why?
|
| Acetyl-CoA Carboxylase | 2 | 2017 | 17 | 0.260 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2018 | 208 | 0.260 |
Why?
|
| Oxidation-Reduction | 2 | 2019 | 325 | 0.260 |
Why?
|
| Fatty Liver | 2 | 2019 | 108 | 0.260 |
Why?
|
| Energy Intake | 2 | 2017 | 171 | 0.250 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 863 | 0.250 |
Why?
|
| Immunoblotting | 2 | 2016 | 204 | 0.250 |
Why?
|
| Mice, Inbred ICR | 3 | 2012 | 32 | 0.240 |
Why?
|
| Eicosanoic Acids | 1 | 2005 | 3 | 0.240 |
Why?
|
| Anticarcinogenic Agents | 1 | 2005 | 78 | 0.230 |
Why?
|
| Male | 8 | 2020 | 29594 | 0.200 |
Why?
|
| Humans | 9 | 2022 | 62931 | 0.200 |
Why?
|
| RNA, Messenger | 2 | 2019 | 1535 | 0.190 |
Why?
|
| Body Size | 1 | 2021 | 24 | 0.180 |
Why?
|
| Eating | 3 | 2007 | 138 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 2 | 2017 | 3394 | 0.170 |
Why?
|
| Reproduction | 1 | 2020 | 92 | 0.160 |
Why?
|
| Enoyl-CoA Hydratase | 1 | 2019 | 2 | 0.160 |
Why?
|
| Biomarkers | 2 | 2016 | 1387 | 0.160 |
Why?
|
| Receptors, Glycine | 1 | 2019 | 9 | 0.160 |
Why?
|
| Adenylate Kinase | 1 | 2019 | 18 | 0.160 |
Why?
|
| Palmitic Acid | 1 | 2019 | 14 | 0.160 |
Why?
|
| Blood Glucose | 2 | 2016 | 483 | 0.150 |
Why?
|
| Fish Oils | 1 | 2019 | 43 | 0.150 |
Why?
|
| Corn Oil | 1 | 2019 | 49 | 0.150 |
Why?
|
| Butadienes | 1 | 2018 | 12 | 0.150 |
Why?
|
| Whey Proteins | 1 | 2019 | 68 | 0.150 |
Why?
|
| Linoleic Acid | 1 | 2018 | 19 | 0.140 |
Why?
|
| Biological Availability | 1 | 2019 | 200 | 0.140 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2018 | 131 | 0.140 |
Why?
|
| Emulsifying Agents | 1 | 2019 | 76 | 0.140 |
Why?
|
| Fatty Acids | 1 | 2019 | 200 | 0.140 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2017 | 60 | 0.140 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 187 | 0.130 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2017 | 28 | 0.130 |
Why?
|
| Nuclear Respiratory Factor 1 | 1 | 2016 | 5 | 0.130 |
Why?
|
| Mitochondrial Dynamics | 1 | 2016 | 7 | 0.130 |
Why?
|
| Mitochondria, Muscle | 1 | 2016 | 16 | 0.130 |
Why?
|
| Mice, 129 Strain | 1 | 2016 | 41 | 0.130 |
Why?
|
| Organelle Biogenesis | 1 | 2016 | 16 | 0.130 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2016 | 34 | 0.130 |
Why?
|
| Sirtuin 1 | 1 | 2016 | 26 | 0.130 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2016 | 16 | 0.130 |
Why?
|
| Ribonucleotides | 1 | 2016 | 19 | 0.130 |
Why?
|
| Endoplasmic Reticulum | 1 | 2017 | 173 | 0.130 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2016 | 14 | 0.130 |
Why?
|
| Isomerism | 1 | 2016 | 28 | 0.130 |
Why?
|
| Edetic Acid | 1 | 2015 | 24 | 0.120 |
Why?
|
| Gene Expression | 1 | 2019 | 838 | 0.120 |
Why?
|
| Adiposity | 1 | 2016 | 83 | 0.120 |
Why?
|
| 3T3 Cells | 1 | 2016 | 110 | 0.120 |
Why?
|
| Proteomics | 1 | 2018 | 284 | 0.120 |
Why?
|
| Milk | 1 | 2016 | 42 | 0.120 |
Why?
|
| Weight Gain | 1 | 2016 | 169 | 0.120 |
Why?
|
| Immunity | 1 | 2016 | 107 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 542 | 0.110 |
Why?
|
| Female | 5 | 2020 | 32587 | 0.110 |
Why?
|
| Atherosclerosis | 1 | 2016 | 152 | 0.110 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2016 | 172 | 0.110 |
Why?
|
| Oxidative Stress | 1 | 2016 | 295 | 0.110 |
Why?
|
| Neonicotinoids | 1 | 2012 | 1 | 0.100 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 452 | 0.100 |
Why?
|
| Mutation | 1 | 2021 | 2607 | 0.100 |
Why?
|
| Cells, Cultured | 1 | 2016 | 2156 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 661 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2007 | 608 | 0.060 |
Why?
|
| Toxicity Tests, Chronic | 1 | 2005 | 1 | 0.060 |
Why?
|
| Rats, Inbred F344 | 1 | 2005 | 53 | 0.060 |
Why?
|
| Microsomes, Liver | 1 | 2005 | 21 | 0.060 |
Why?
|
| Proteinuria | 1 | 2005 | 41 | 0.060 |
Why?
|
| Lipoprotein Lipase | 1 | 2005 | 14 | 0.060 |
Why?
|
| Glycerol | 1 | 2005 | 32 | 0.060 |
Why?
|
| Organ Size | 1 | 2005 | 172 | 0.060 |
Why?
|
| Renal Insufficiency | 1 | 2005 | 66 | 0.060 |
Why?
|
| Longevity | 1 | 2005 | 113 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2005 | 368 | 0.050 |
Why?
|
| Kidney | 1 | 2005 | 444 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2005 | 751 | 0.050 |
Why?
|
| Rats | 1 | 2005 | 1982 | 0.040 |
Why?
|
| Cell Line | 1 | 2005 | 2036 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2007 | 2188 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2019 | 381 | 0.040 |
Why?
|